Literature DB >> 21983130

Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma.

Xiaoyue Chen1, Qin Yan, Shuangdi Li, Long Zhou, Huajing Yang, Yixia Yang, Xuelian Liu, Xiaoping Wan.   

Abstract

This study investigated the role of miR-206 in estrogen receptor-α (ERα)-positive endometrial endometrioid adenocarcinoma (EEC). We profiled miR-206 expression in 30 EEC clinical samples using qRT-PCR, and explored its relationship with ERα and clinical parameters. A luciferase reporter assay assessed the ERα targeting potential of miR-206. Functional analyses of miR-206 were performed in EEC cell lines. MiRNA-206 expression decreased in ERα-positive EECs, and its expression was negatively correlated with ERα. MiRNA-206 overexpression inhibited ERα-dependent proliferation, impaired invasiveness and induced cell cycle arrest of ERα-positive EEC cell lines. Therefore, aberrantly expressed miRNA-206 may be associated with the development of ERα-positive EEC.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983130     DOI: 10.1016/j.canlet.2011.09.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  44 in total

1.  Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.

Authors:  Rong Tian; Tao Liu; Li Qiao; Mei Gao; Jing Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2.

Authors:  X L Ren; G Y He; X M Li; Hui Men; L Z Yi; G F Lu; S N Xin; P X Wu; Y L Li; W T Liao; Y Q Ding; L Liang
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-29       Impact factor: 4.553

3.  Effects of photoelectric therapy on proliferation and apoptosis of scar cells by regulating the expression of microRNA-206 and its related mechanisms.

Authors:  Song Zhang; Zhen-Min Zhao; Hong-Yu Xue; Fang-Fei Nie
Journal:  Int Wound J       Date:  2019-12-18       Impact factor: 3.315

Review 4.  Regulation of the mRNA half-life in breast cancer.

Authors:  Paola Griseri; Gilles Pagès
Journal:  World J Clin Oncol       Date:  2014-08-10

5.  Decreased expression of microRNA-206 correlates with poor clinical outcome in patients with malignant astrocytomas.

Authors:  Shuai Wang; Shengkui Lu; Shaomei Geng; Shucheng Ma; Zhaohui Liang; Baohua Jiao
Journal:  Pathol Oncol Res       Date:  2014-01-05       Impact factor: 3.201

Review 6.  miRNAs and estrogen action.

Authors:  Carolyn M Klinge
Journal:  Trends Endocrinol Metab       Date:  2012-04-11       Impact factor: 12.015

Review 7.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

8.  Correlations of common polymorphism of EVI-1 gene targeted by miRNA-206/133b with the pathogenesis of breast cancer.

Authors:  Tian-Yi Wang; Yin-Peng Huang; Ping Ma
Journal:  Tumour Biol       Date:  2014-06-17

9.  MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET.

Authors:  Xi Chen; Zhong-Kai Tong; Jian-Ya Zhou; Ya-Ke Yao; Shu-Meng Zhang; Jian-Ying Zhou
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

Review 10.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.